EB-2 NIWHealthcare, clinicalIndividualDecided 2024Dismissed
Outcome: Dismissed
JUL112024_11B5203
Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed
Our summary
Pharmacist and entrepreneur sought EB-2 with national interest waiver to develop wellness business and compounding pharmacy. AAO affirmed denial, finding proposed endeavor failed to demonstrate national importance under Dhanasar; business plan showed growth potential but no evidence of substantial positive economic effects or broader field impact.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Business plan for wellness products and compounding pharmacy lacked objective evidence of prospective national impact or industry-wide implications
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Not met | Business plan for wellness products and compounding pharmacy lacked objective evidence of prospective national impact or industry-wide implications |
 Well positioned | Not reached / not discussed | Not reached because first prong failed; decision reserved judgment on remaining prongs |
 Balance favors a waiver | Not reached / not discussed | Not reached because first prong failed; decision reserved judgment on remaining prongs |
A published decision describes one case. It is not legal advice and not a prediction for yours.